Healthcare
NRX Pharmaceuticals misses earnings, revenue forecasts
Quarterly loss of $0.33 per share and revenue shortfall reported as company cites higher R&D costs.
Teva Pharmaceuticals stock nears yearly high: Buy or hold?
Shares of Teva Pharmaceuticals have risen sharply, prompting questions about valuation and investment potential amid broader sector trends.
Cochlear FY26 outlook: cash flow doubles despite margin squeeze
Australia’s hearing implant maker projects strong cash flow growth for FY26 even as operating margins face pressure from rising costs and competitive pricing.
Zoetis shares hit 52-week low of $71.41
Pharmaceutical firm Zoetis sees stock fall to its lowest level since mid-2023, tracking broader sector weakness.
Cogstate posts FY26 revenue miss despite strong growth forecast
Cogstate Ltd. forecasted strong FY26 growth but missed revenue expectations, leading to a sharp decline in its share price. Analysts weigh the outlook.
Aspen Group shares surge on strong quarterly results
The healthcare REIT reported better-than-expected revenue and profit for Q2, lifting shares by over 15% in early trading.
Cochlear shares rise on earnings upgrade, dividend boost
Australian hearing implant maker lifts full-year profit guidance and announces higher dividend as demand for its devices accelerates globally.